Literature DB >> 8782285

First-episode schizophrenia: II. Premorbid patterns by gender.

T K Larsen1, T H McGlashan, J O Johannessen, L Vibe-Hansen.   

Abstract

This article describes the application of the Premorbid Adjustment Scale to Norwegian subjects with first-episode schizophrenia. The scale measures premorbid functioning from several perspectives: functioning at different developmental periods, change of functioning over time, and distinctive patterns of functioning over time. Gender differences were striking, with males scoring poorer and deteriorating faster than females, especially closer to onset. While the duration of untreated psychosis (DUP) was significantly longer in males, correlations between DUP and premorbid functioning within gender were largely nonsignificant, as were the analyses of premorbid functioning and age at onset. On the other hand, we replicated studies that found associations between poorer premorbid functioning and insidious onset and negative symptoms. Overall, our premorbid patterns suggest that a process of asymptomatic premorbid deficit formation precedes onset by some period, especially among males. The patterns also suggest that active symptom formation does not always precede this deteriorative process.

Entities:  

Mesh:

Year:  1996        PMID: 8782285     DOI: 10.1093/schbul/22.2.257

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  20 in total

1.  Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders.

Authors:  Sarah I Tarbox; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Robert Heinssen; Thomas H McGlashan; Scott W Woods
Journal:  Psychiatry Res       Date:  2013-10-18       Impact factor: 3.222

2.  Trajectories of premorbid childhood and adolescent functioning in schizophrenia-spectrum psychoses: A first-episode study.

Authors:  Leslie E Horton; Sarah I Tarbox; Thomas M Olino; Gretchen L Haas
Journal:  Psychiatry Res       Date:  2015-03-02       Impact factor: 3.222

3.  Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk".

Authors:  Cheryl Corcoran; Dolores Malaspina; Laura Hercher
Journal:  Schizophr Res       Date:  2005-03-01       Impact factor: 4.939

Review 4.  Sex steroids and schizophrenia.

Authors:  Julie A Markham
Journal:  Rev Endocr Metab Disord       Date:  2012-09       Impact factor: 6.514

5.  Sex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia.

Authors:  Evgeny Bychkov; M Rafiuddin Ahmed; Eugenia V Gurevich
Journal:  Int J Neuropsychopharmacol       Date:  2010-02-17       Impact factor: 5.176

Review 6.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

7.  Differences in developmental changes in academic and social premorbid adjustment between males and females with schizophrenia.

Authors:  Daniel N Allen; Gregory P Strauss; Kimberly A Barchard; Mary Vertinski; William T Carpenter; Robert W Buchanan
Journal:  Schizophr Res       Date:  2013-03-13       Impact factor: 4.939

8.  Lack of Gender-Related Differences in Childhood-Onset Schizophrenia.

Authors:  Anna E Ordóñez; Frances F Loeb; Xueping Zhou; Lorie Shora; Rebecca A Berman; Diane D Broadnax; Peter Gochman; Siyuan Liu; Judith L Rapoport
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-07-01       Impact factor: 8.829

9.  History of religious delusions and psychosocial functioning among Mexican patients with paranoid schizophrenia.

Authors:  Rebeca Robles-García; Sonia López-Luna; Francisco Páez; Raúl Escamilla; Beatriz Camarena; Ana Fresán
Journal:  J Relig Health       Date:  2014-12

10.  Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia.

Authors:  Stephanie M Perez; Li Chen; Daniel J Lodge
Journal:  Psychoneuroendocrinology       Date:  2014-05-14       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.